How should I initiate lithium 400 mg at night for an outpatient with bipolar affective disorder, including required baseline investigations, contraindications, monitoring schedule, and dose titration?

Initiating Lithium 400mg Nightly for Bipolar Affective Disorder in Outpatient Setting

Direct Recommendation

Start lithium carbonate 400mg once daily at bedtime after completing baseline investigations, with target serum level of 0.8-1.2 mEq/L for acute treatment, checking lithium level 5 days after initiation and titrating by 300mg increments weekly until therapeutic levels are achieved or response criteria are met. 1, 2

---

Mandatory Baseline Investigations Before First Dose

Complete the following laboratory assessment before prescribing the first dose of lithium:

• Complete blood count to establish baseline hematologic parameters 1, 2
• Thyroid function tests (TSH and free T4) as lithium commonly causes hypothyroidism 1, 2
• Renal function panel including BUN, serum creatinine, and urinalysis to assess baseline kidney function 1, 2
• Serum calcium to detect pre-existing hyperparathyroidism 1, 2
• Pregnancy test in all females of childbearing potential due to teratogenic risk 1, 2
• Baseline ECG if patient is over 40 years old or has cardiac risk factors 1

---

Absolute Contraindications to Lithium Initiation

Do not prescribe lithium if any of the following are present:

• Severe renal impairment (creatinine clearance <30 mL/min) as lithium is renally excreted and toxicity risk is unacceptably high 2
• Pregnancy (first trimester especially) due to cardiac teratogenicity risk 2
• Acute dehydration or sodium depletion as these conditions dramatically increase lithium toxicity risk 2
• Uncontrolled thyroid disease until stabilized on thyroid replacement 2
• Active substance abuse particularly stimulants or alcohol, which destabilize fluid/electrolyte balance 1

---

Dosing Strategy and Titration Schedule

Initial Dosing

• Start with 400mg once daily at bedtime rather than divided dosing to improve tolerability and reduce urinary frequency 3
• Once-daily dosing produces fewer renal adverse effects and requires lower total daily doses compared to twice-daily schedules 3
• For patients weighing <30 kg, start with 300mg once daily instead 1

Titration Protocol

• Check serum lithium level 5 days after starting (after reaching steady state) and 12 hours post-dose 1, 2
• Increase by 300mg weekly if level is subtherapeutic (<0.8 mEq/L) and patient tolerates current dose 1
• Target therapeutic range is 0.8-1.2 mEq/L for acute mania treatment 1, 2
• Some patients respond at lower concentrations (0.6-0.8 mEq/L), but therapeutic monitoring guides optimization 1, 2
• Typical maintenance dose ranges from 900-1800mg daily once therapeutic levels are achieved 1

---

Ongoing Monitoring Schedule

First 6-8 Weeks (Acute Phase)

• Check lithium level weekly during dose titration until stable therapeutic level achieved 1, 2
• Assess clinical response weekly using standardized measures if available 1
• Monitor for early toxicity signs including fine tremor, nausea, diarrhea, and polyuria 1

Maintenance Phase (After Stabilization)

• Lithium level every 3-6 months to ensure therapeutic range maintained 1, 2
• Renal function (BUN, creatinine, urinalysis) every 3-6 months to detect nephrotoxicity early 1, 2
• Thyroid function (TSH) every 3-6 months as lithium-induced hypothyroidism develops in 20-30% of patients 1, 2
• Serum calcium annually to screen for hyperparathyroidism 1

---

Critical Patient Education Points

Medication Storage and Safety

• Secure lithium in locked location and remove access to lethal quantities, particularly in patients with suicidal ideation 1
• Prescribe limited quantities (1-2 weeks supply) with frequent refills to minimize stockpiling risk in high-risk patients 1
• Lithium overdoses can be fatal; third-party medication supervision is essential for patients with suicide history 1

Maintaining Stable Lithium Levels

• Maintain consistent sodium and fluid intake as dehydration or sodium restriction dramatically increases lithium levels and toxicity risk 2
• Avoid NSAIDs (ibuprofen, naproxen) as they reduce lithium clearance and increase levels by 30-50% 2
• Report any illness causing vomiting, diarrhea, or fever immediately as these increase toxicity risk 1

Recognizing Lithium Toxicity

• Early signs include fine tremor, nausea, diarrhea, increased urination, and thirst 1
• Seek immediate medical attention if coarse tremor, confusion, slurred speech, ataxia, or muscle twitching develop 1
• These symptoms indicate severe toxicity requiring emergency evaluation 1

---

Expected Timeline for Clinical Response

• Therapeutic effects become apparent after 1-2 weeks at therapeutic lithium levels 1
• Full response requires 4-6 weeks at adequate doses before concluding effectiveness 1
• Response rates for acute mania range from 38-62%, meaning some patients respond robustly while others may require combination therapy 1

---

When to Add Combination Therapy

If inadequate response after 6-8 weeks at therapeutic lithium levels (0.8-1.2 mEq/L):

• Add an atypical antipsychotic (aripiprazole 10-15mg, risperidone 2-3mg, or quetiapine 400-600mg) for severe mania or psychotic features 1
• Combination therapy is superior to monotherapy for treatment-resistant cases and severe presentations 1
• Never conclude lithium failure without documenting therapeutic levels for adequate duration 1

---

Maintenance Therapy Duration

• Continue lithium for minimum 12-24 months after achieving mood stabilization 1, 2
• Some patients require lifelong treatment when benefits outweigh risks, particularly those with multiple severe episodes or rapid cycling 1, 2
• Withdrawal of lithium dramatically increases relapse risk, especially within 6 months of discontinuation, with >90% of noncompliant patients relapsing versus 37.5% of compliant patients 1, 2

---

Unique Anti-Suicide Benefit

• Lithium reduces suicide attempts 8.6-fold and completed suicides 9-fold, an effect independent of its mood-stabilizing properties 1
• This anti-suicide effect is mediated through central serotonin-enhancing properties 1
• Lithium is the only mood stabilizer with robust evidence for suicide prevention 1

---

Common Pitfalls to Avoid

• Never start lithium without baseline renal and thyroid function as pre-existing dysfunction contraindicates use or requires dose adjustment 2
• Never discontinue lithium abruptly as this causes rebound mania in the majority of patients; taper over 2-4 weeks minimum if discontinuation is necessary 1
• Never rely on subtherapeutic levels (<0.6 mEq/L) as adequate trial; one in 10 patients prescribed lithium have subtherapeutic levels explaining apparent treatment failure 4
• Never ignore polyuria or polydipsia as these may indicate nephrogenic diabetes insipidus requiring dose reduction or discontinuation 1
• Never combine with NSAIDs without close monitoring as this combination frequently causes lithium toxicity 2

---

Adjunctive Psychosocial Interventions

• Provide psychoeducation about bipolar disorder symptoms, course, treatment options, and critical importance of medication adherence 1
• Implement family-focused therapy to help with medication supervision, early warning sign identification, and reducing access to lethal means 1
• Add cognitive-behavioral therapy once acute symptoms stabilize to improve long-term adherence and outcomes 1
• Psychosocial interventions combined with pharmacotherapy produce superior outcomes compared to medication alone 1